| Term 
 | Definition 
 
        |         Any undesirable occurance related to administering or failing to administer a prescribed medication   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       Any chemical that effects the physiological processes of a living organism. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       Any unexpected, unintended, undesired, or excessive response to a medication given at therapeutic dosages (as exposed to overdose)   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     Drug interactions in which the effect of a combination of two or more drugs with similar actions is equivalant to the sum of the individual effects of the same drugs given alone. 1 + 1 = 2 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       a drug that binds to and stimulates the activity of one or more receptors in the body |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     an immunologic hypersensitivity reaction resulting from the unusually sensitivity of a patient to a particular medication; a type of adverse drug event |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       A drug that binds to and inhibits the activity of one or more receptors in the body; also called an inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       drug interactions in which the effect of a combination of two or more drugs is less than the sum of individual effects of the same drugs given alone. Usually caused by a blocking or reducing effect of one drug on another |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       A measure of the extent of drug absorption for a given drug and route |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     one or more biochemical reactions involving a parent drug: occurs mainly in the liver and produces a metabolite that is either inactive or active |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the barrier system that restricts the passage of various chemicals and microscopic entities between the blood stream and the central nervous system. Allows passage of the essential substances such as oxygen |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |         The name that describes the chemical composition and molecular structure of a drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       Any condition; especially one related to a disease stare or other patient characteristic, including current or recent drug therapy that renders a particular form of treatment improper or undesirable |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     The general name for a large class of enzymes that play a significant role in drug metabolism.  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     a state in which there is a compulsive or chronic need for a drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       The process by which solid forms of  drugs disintegrate  into the gastrointestinal tract and become soluble before being absorbed into the circulation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the cellular processes involved in the interaction between a drug and body cells; also called mechanism of action |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     The physiological reactions of the body to a drug. They can be therapeutic or toxic and decide how the function of the body is affected as a whole by the drug. The terms onset, peak and duration are used to describe drug effects.  |  | 
        |  | 
        
        | Term 
 
        |       Drug induced teratogenisis:  |  | Definition 
 
        |     the development of congenital anomalies or defects in the developing fetus caused by the toxic effects of drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     Alteration in the pharmacologic activity of a given drug caused by the presence of one or more additional drugs; it is usually related to the effects on the enzymes required for metabolism of the involved drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the length of time the concentration of a drug in the blood or tissues is sufficient to elicit a response |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     Protein molecules that catalyze one or more of a variety of biochemical reactions, including those related to the body’s own physiologic processes as well as those related to drug metabolism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     The initial metabolism in the liver of a drug absorbed from the gastrointestinal tract before the drug reaches systemic circulation through the bloodstream |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the name given to a drug by the United States Adopted Names Council. Also called the nonproprietary name. the generic name is much shorter and simpler than the chemical name and is not protected by trademark |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     In pharmokinetics, the time required for half of an administered dose of a drug to be eliminated from the body, or the time it takes for the blood level of a drug to be reduced by 50% |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       An abnormal and unexpected response to a medication, other than an allergic reaction, that is peculiar to and individual patient |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the characteristic that causes two parenteral drugs or solutions to undergo a reaction when mixed or given together that results in the chemical deterioration of at least one of  |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        |     any preventable adverse drug  event involving inappropriate medication use by a patient or healthcare professional; may or may not cause patient harm |  | 
        |  | 
        
        | Term 
 
        |     Medication use processes:  |  | Definition 
 
        |       the prescribing, dispensing and administering of medications, and the monitoring of their effects  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 a chemical form of a drug that is the product of one or more biochemical (metabolic) reactions involving the parent drug. Active metabolites are those that have pharmacologic activity of their own, even if the parent drug is inactive. Inactive metabolites lack pharmacological activity and are simply drug waste products awaiting excretion from the body |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the time required for a drug to elicit a therapeutic response after dosing |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 
 the chemical form of a drug that is administered before it is metabolized by the body’s biochemical reactions into is active or inactive metabolites. A parent drug that is not pharmacologically active itself is called a prodrug. A prodrug is then metabolized to pharmacologically active metabolites |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the time required for a drug to reach its maximum therapeutic responses in the body |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the maximum concentration of a drug in the body after administration, usually measured in a blood sample for therapeutic drug monitoring |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the science of preparing and dispensing drugs, including dosage from design |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | the study of the biochemical and physiologic interactions of drugs at there sites of activity. It examines the physicochemical properties of drugs and their pharmacologic interactions with body receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   the study of the influence of genetic factors on drug responses, including the nature of genetic aberrations that result in the absence, overabundance, or insufficiency of drug-metabolizing enzymes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the study of drugs that are obtained from natural plant and animal sources  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the rate of drug distribution among various body compartments after a drug has entered the body. It includes the phases of absorption, distribution, metabolism, and excretion of drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the broadest term for the study or the science of drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the treatment of pathologic conditions through the use of drugs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     an inactive drug dosage form that is converted to an active metabolite by various biochemical reactions once its inside the body |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   A molecular structure within or on the outer surface of a cell. Receptors bind specific substances and one or more corresponding cellular effects occurs as a result of this drug-receptor interaction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   the physiologic state in which the amount of drug removed via elimination is equal to the amount of drug absorbed with each dose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     substances on which enzymes act |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | drug interactions in which the effect of a combination of two or more drugs with similar actions is greater than the sum of individual effects of the same drugs given alone |  | 
        |  | 
        
        | Term 
 
        |     Therapeutic drug monitoring |  | Definition 
 
        |     the process of measuring drug peak and trough levels to gauge the level of a patient’s drug exposure and allow adjustment of dosages with the goals of maximizing therapeutic effects and minimizing toxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the desired or intended effect of a particular medication |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the ratio between the toxic and therapeutic concentrations of a drug |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       reduced response to a drug after prolonged use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the quality of being poisonous |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the condition of producing adverse bodily effects due to poisonous qualities |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       the study of poisons, including toxic drug effects, and applicable treatments |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     the commercial name given to a drug product by its manufacture; also called the proprietary name |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | the lowest concentration of drug reached in the body after it falls from its peak level, usually measured in a blood sample for therapeutic drug monitoring |  | 
        |  |